Allstate Corporation’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Allstate Corporation's HALO Position: Q3 2026 in Review
Allstate Corporation reduced its Halozyme (HALO) stake by 13% in Q3 2026, selling an estimated $162K and leaving 11,593 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #525.
Allstate Corporation first reported a position in HALO in Q1 2026 and has held it in 3 quarters since. 714 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Allstate Corporation held 11,593 shares of Halozyme worth $1.28M as of Q3 2026.
- Allstate Corporation sold 1,678 Halozyme shares in Q3 2026, an estimated $162K.
- Halozyme made up 0.01% of Allstate Corporation's portfolio in Q3 2026, its #525 holding.
- Allstate Corporation first reported a position in Halozyme in Q1 2026 and has held it in 3 quarters since.
- 714 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Allstate Corporation's 13F filing for Q3 2026, filed 16 Nov 2026.